Company Profiles

driven by the PitchBook Platform

Precision BioSciences

Precision BioSciences
2006 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
2ndary - Private LATEST DEAL TYPE
$131M TOTAL AMOUNT RAISED
8 INVESTORS
Description

Developer of therapeutics and services based on genomic molecular biology. The company offers bio-therapeutics, a directed nuclease editor therapeutic targeted to enable the in situ correction of genes responsible for human diseases and meganucleases used to engineer cell lines for disease models or optimize cell lines for the bio-manufacturing of protein vaccines.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
302 East Pettigrew Street
Dibrell Building, Suite A-100
Durham, NC 27701
United States

+1 (919) 314-5512
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Precision BioSciences’s full profile, request a free trial.

Precision BioSciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private $131M Completed Generating Revenue
3. Grant 23-May-2016 00.00 00000 Completed Generating Revenue
2. Corporate 25-Feb-2016 $105M $131M Completed Generating Revenue
1. Later Stage VC (Series A) 11-May-2015 $25.6M $25.6M $100M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Precision BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table request access »

Precision BioSciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Baxalta Corporation Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
North Carolina Biotechnology Center Not-For-Profit Venture Capital 000 0000 000000 0
Osage University Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Precision BioSciences Executive Team (8)

Name Title Board
Seat
Contact
Info
Matthew Kane Co-Founder, Chief Executive Officer & Board Member
Todd Melby Chief Financial Officer & Chief Operations Officer
Jeff Smith Ph.D Chief Technical Officer, Co-Founder & Chief Science Officer
Derek Jantz Co-Founder, Chief Scientific Officer & Board Member
Bruce McCreedy Ph.D Senior Vice President, Cell Therapy
You’re viewing 5 of 8 executives. Get the full list »

Precision BioSciences Board Members (4)

Name Representing Role Since Contact
Info
Benjamin Auspitz Self Board Member 000 0000
Derek Jantz Precision BioSciences Co-Founder, Chief Scientific Officer & Board Member 000 0000
Matthew Kane Precision BioSciences Co-Founder, Chief Executive Officer & Board Member 000 0000
Robert Adelman MD venBio Board Member 000 0000